Total Revenue: $14.3 million for Q3 2025, compared to negative $1.8 million in Q3 2024. Torii Milestone and Collaboration Revenue: $10.7 million in Q3 2025. Net YCANTH Revenue: $3.6 million in Q3 2025 ...

WEST CHESTER, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases ...

While much of the Epstein files remain sealed, several high-profile people have been named in some of the released documents Jordana Comiter is an Associate Editor on the Evergreen team at PEOPLE. She ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

We all download a vast number of files on our devices every day. Many of the files we download can get lost in our vast list of downloads. In such a scenario, having a file open automatically upon ...

Shares of Verrica Pharmaceuticals Inc. (VRCA) have been struggling lately and have lost 15.3% over the past week. However, a hammer chart pattern was formed in its last trading session, which could ...

Faith writes guides, how-tos, and roundups on the latest Android games and apps for Android Police. You'll find her writing about the newest free-to-play game to hit Android or discussing her paranoia ...

“A nation that is afraid to let its people judge the truth and falsehood in an open market is a nation that is afraid of its people.” – John F. Kennedy On November 22, 1963, crowds of excited people ...

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q4 2024 Earnings Call Transcript March 11, 2025 Verrica Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.24, expectations were $-0.25.

Fintel reports that on November 5, 2024, RBC Capital downgraded their outlook for Verrica Pharmaceuticals (NasdaqGM:VRCA) from Outperform to Sector Perform. Analyst Price Forecast Suggests 1,550.90% ...